Nitish Nachiappan

Nitish Nachiappan

Auto-generated profile, based on publicly available information

Nitish Nachiappan

School of Public Health Imperial College School of Medicine London UK

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2019 in Journal of Pain Research
Verified
Journal Article
Open access
PDF file
RMRenee Siu Yu Ma
Renee Siu Yu Ma
Kayani KayaniKayani Kayani
Kayani Kayani
DODanniella Whyte Oshodi
Danniella Whyte Oshodi
AOAiyesha Whyte Oshodi
Aiyesha Whyte Oshodi
NNNitish Nachiappan
Nitish Nachiappan
RMRaihan Mohammed
Raihan Mohammed
Being maladaptive and frequently unresponsive to pharmacotherapy, chronic pain presents a major unmet clinical need. While an intact central nervous system is required for conscious pain perception, nociceptor hyperexcitability induced by nerve injury in the peripheral nervous system (PNS) is sufficient and necessary to initiate and maintain neuropathic pain. The genesis and propagation of action potentials is dependent on voltage-gated sodium channels, in particular, Nav1.7, Nav1.8 and Nav1.9. However, nerve injury triggers changes in their distribution, expression and/or biophysical properties, leading to aberrant excitability. Most existing treatment for pain relief acts through non-selective, state-dependent sodium channel blockage and have narrow therapeutic windows. Natural toxins and developing subtype-specific and molecular-specific sodium channel blockers show promise for treatment of neuropathic pain with minimal side effects. New approaches to analgesia include combination therapy and gene therapy. Here, we review how individual sodium channel subtypes contribute to pain, and the attempts made to develop more effective analgesics for the treatment of chronic pain.

20 July 2022 in Health Science Reports
Verified
Journal Article
Open access
NNNitish Nachiappan
Nitish Nachiappan
SMShona Mackinnon
Shona Mackinnon
JNJean P. Ndayizeye
Jean P. Ndayizeye
GGGeva Greenfield
Geva Greenfield
DHDougal Hargreaves
Dougal Hargreaves
Background: Previous studies focusing on high‐income countries have shown that young people often face greater barriers to accessing healthcare than older adults. However, in low‐middle income countries (LMICs), there have been a paucity of cross‐country, quantitative studies highlighting these barriers.Aim: This exploratory study aims to provide a scoping review of the publicly available Demographic and Heath Survey (DHS) data with a view to form the basis for further work.Materials and methods: Data on insurance coverage, agency, and access to evidence‐based family planning from 30 countries in the DHS were compared between age groups. Data on 586,250 participants 15–24 years (33% male) and 854,660 participants 25–49 years (16% male) from 30 LMICs were analyzed.Results: Significantly greater barriers to accessing healthcare were observed across six variables in younger population when compared to older adults across all survey questions with an average of 8.4% point difference. Also, there was wide country‐level variation: the maximum differences between age groups were 33% points; Rwanda was the only country with no age differences.Discussion: This study highlights several possible themes for future research into improving access to healthcare for young people. These themes include more detailed evaluation of country‐specific policies to reduced barriers to healthcare for young people and further research into the causative factors that can influence healthcare utilization by young people.Conclusion: Our analysis showcases increased barriers to healthcare access for young people in LMICs. We argue that they can only be improved by targeted policies and direct community engagement.